Stocks · Korea 222110 KOSDAQ

Pangen Biotech

4,735원 -0.21% Market cap 640억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER30.75x
PBR2.13x
EPS154 KRW
BPS2,218 KRW
ROE6.73%
DPS0 KRW

Returns and 52-week range

1W+0.21%
1M-4.73%
3M-0.94%
6M-7.34%
1Y-21.61%
YTD-14.38%
52W high8,510원
52W low4,220원
From 52W high-44.36%

Financial results (separate)

PeriodRevenueOperating incomeNet incomeOP margin
202265억-46억-45억-70.6%
202373억-42억-45억-57.8%
2024147억10억9억7.0%
2025134억15억21억11.2%
Quarterly
2024 4Q43억-3억-5억-6.4%
2025 1Q34억7억7억20.4%
2025 2Q35억8억9억23.9%
2025 3Q40억4억5억9.4%
2025 4Q25억-4억-1억-16.3%
2026 1Q37억5억8억12.9%

Company

CEO윤재승
Founded2010-01-29
Fiscal year end12
Address: 경기도 수원시 영통구 신원로 306, 2동 4층(원천동 영통이노플렉스) &nbsp

Peers in the same sector

CompanyMarket capP/EP/B1M
옵티팜657억—2.59-6.96%
HLB파나진621억—0.86+21.79%
팜젠사이언스662억—0.44-7.01%
유유제약605억7.800.54+0.92%
이엔셀662억—1.66+11.11%
쿼드메디슨580억—1.86+2.86%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.